查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1927374

周邊PMT導管市場按產品類型、導管尺寸、應用、最終用戶和銷售管道分類 - 全球預測（2026-2032年）

Peripheral PMT Catheter Market by Product Type, Catheter Size, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，周邊 PMT 導管市場價值將達到 4.581 億美元，到 2026 年將成長至 4.9757 億美元，到 2032 年將達到 7.4739 億美元，年複合成長率為 7.24%。

關鍵市場統計數據
基準年 2025 4.581億美元
預計年份：2026年 4.9757億美元
預測年份 2032 7.4739億美元
複合年成長率 (%) 7.24%

整合臨床進展、採購實務和設備性能預期，為周邊PMT導管的引入建構策略背景

周邊經皮機械血栓切除術（PMT）導管領域正處於不斷發展的血管內技術和日益成長的微創治療臨床需求的交匯點。臨床醫生越來越傾向於選擇導航精準、血栓切除速度快且與現有介入手術室相容的器械，而採購團隊則要求產品在臨床療效、可預測的供應鏈和售後服務支援之間取得平衡。不斷發展的器械架構和手術流程的融合，重新定義了人們對導管性能的預期，尤其是在複雜周邊血管疾病的介入治療中，因為這類疾病的血管迂曲度、血栓負荷和入路因素都存在很大差異。

技術、醫療服務模式、監管要求和供應鏈韌性等因素的整合如何重塑周邊PMT導管的推廣應用路徑

周邊經皮機械通氣（PMT）導管的市場格局正受到多重因素的共同影響，這些因素正在重塑臨床實踐和商業性策略。技術進步日新月異，催生出更精密複雜的導管設計，這些設計強調導管的操控性和扭矩響應，以適應複雜的外周解剖結構。此外，輔助影像和設備整合功能的提升進一步增強了病灶的可視化效果和手術精準度，從而縮短了手術時間，並降低了經驗豐富的醫生操作時的併發症率。

了解2025年美國關稅調整對周邊PMT導管供應鏈重組、採購在地化和籌資策略的影響

2025年，美國關稅政策的變化將對周邊PMT導管的籌資策略和製造商分銷邏輯產生重大影響。醫療設備及零件進口關稅的提高迫使跨國製造商重新評估其產品流、定價結構和本地化計劃，以保持市場競爭力。隨著各機構的調整，醫院和門診中心的採購負責人正在積極探索替代貨源、簽訂長期合約以及建立供應商夥伴關係關係，以確保設備供應穩定，同時降低短期成本波動。

多維度細分框架揭示了應用、最終用戶、產品類型、銷售管道和導管尺寸如何共同影響臨床應用和商業策略。

市場區隔在解讀周邊PMT導管的需求趨勢、產品開發重點和市場推廣策略方面發揮核心作用。從臨床應用角度來看，這些器械廣泛應用於透析通路管理、栓塞治療和周邊血管疾病治療。尤其是在周邊血管疾病治療中，根據病變特徵和手術目標，會選擇針對血管成形術輔助、動脈粥狀硬化斑塊切除術切除術輔助或標靶血栓切除術最佳化的器械。這些臨床差異會影響器械的特性，例如管腔大小、抽吸能力以及與輔助器械的相容性。

美洲、歐洲、中東和非洲以及亞太地區在法規結構、臨床實務和採購體系方面的差異，會影響醫療器材策略和市場准入。

區域趨勢將對周邊PMT導管的監管路徑、臨床實務模式和商業性推廣產生重大影響。在美洲，成熟的介入性心臟病學和放射學體系、完善的醫院採購框架以及對門診血管護理日益成長的重視推動了臨床應用，所有這些因素都有利於那些展現出高效操作性和臨床醫生熟練度的器械。該地區的監管和報銷環境鼓勵將器械性能與患者預後和成本控制聯繫起來的證據。

PMT導管領域的競爭格局：規模、專注創新和一體化服務推動差異化並影響採購決策。

周邊PMT導管市場的競爭反映了成熟醫療設備製造商和新興專業公司並存的局面，後者專注於導管設計和手術輔助器具的創新。成熟製造商利用其廣泛的臨床關係、大規模生產和一體化的產品系列，提供包含導管、導管導引線和影像附件的捆綁式解決方案。其規模優勢使其能夠投資於多中心臨床研究、廣泛的培訓項目以及全球分銷網路，從而支持醫院系統採用這些產品。

為製造商和醫療保健提供者提供切實可行的策略性舉措，以協調產品開發、證據產生和供應鏈模式與臨床和採購優先事項。

產業領導者可以透過一系列有針對性的實用舉措，將洞察轉化為競爭優勢，這些舉措旨在使產品設計、商業模式和證據產生與不斷變化的臨床和採購需求保持一致。首先，他們應優先考慮模組化產品架構，以便快速客製化導管屬性，例如直徑和輸送配置，同時降低庫存管理的複雜性。這種方法可以減輕高容量醫療機構的物流負擔，並支持臨床醫生在各種病例類型中快速採用此方法。

我們採用透明的混合方法調查方法，結合臨床醫師訪談、採購洞察和技術文獻綜合，得出可複製的策略結論。

本分析所依據的研究採用跨學科方法，將一手質性資料與二手技術和監管文獻結合。一手資料包括對介入醫師、醫院和門診中心的採購主管以及負責分銷和銷售策略的商業領導者的結構化訪談。這些第一手觀點揭示了影響技術採納模式的程序偏好、採購理由和營運限制。

摘要強調了整合產品創新、臨床檢驗和供應鏈前瞻性對於實現周邊PMT導管的持續應用的重要性。

周邊經皮機械取栓（PMT）導管市場的特點是技術快速創新、醫療服務模式不斷變化以及對供應鏈韌性的日益重視。成功駕馭此環境需要臨床價值提案與切實可行的商業性執行方案相契合。臨床醫生需要能夠提高手術精準度和改善患者預後的器械，而採購團隊則需要可預測的供應和可證明的整體成本效益。製造商必須透過實證醫學證據、培訓和可靠的物流保障來滿足這些需求。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 周邊PMT導管市場（依產品類型分類）

  • 越過電線
  • 快速交換類型
  • 專業化配送系統
    • 可轉向
    • 扭力控制

9. 依導管尺寸分類的周邊PMT導管市場

  • 大直徑 > 3.5F
  • 中等直徑 2.5-3.5F
  • 小直徑<2.5F

第10章 依應用分類的外周PMT導管市場

  • 透析通路管理
  • 栓塞術
  • 周邊血管疾病治療
    • 血管成形術
    • 動脈粥狀硬化斑塊切除術
    • 血栓切除術

第11章 周邊PMT導管市場（依最終用戶分類）

  • 門診手術中心
  • 醫院
  • 專科診所

第12章 周邊PMT導管市場（依銷售管道分類）

  • 直銷
  • 批發的

13. 周邊PMT導管市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 周邊PMT導管市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國周邊PMT導管市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國周邊PMT導管市場

第17章：中國周邊PMT導管市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AngioDynamics, Inc.
  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Inari Medical, Inc.
  • Koninklijke Philips NV
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Penumbra, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-4F7A6D4FF382

The Peripheral PMT Catheter Market was valued at USD 458.10 million in 2025 and is projected to grow to USD 497.57 million in 2026, with a CAGR of 7.24%, reaching USD 747.39 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 458.10 million
Estimated Year [2026] USD 497.57 million
Forecast Year [2032] USD 747.39 million
CAGR (%) 7.24%

Framing the strategic context for peripheral PMT catheter adoption by synthesizing clinical advances, procurement realities, and device performance expectations

The peripheral percutaneous mechanical thrombectomy (PMT) catheter segment sits at the intersection of advancing endovascular techniques and intensifying clinical demand for minimally invasive therapies. Clinicians increasingly prefer devices that offer precise navigation, rapid thrombus removal, and compatibility with existing interventional suites, while procurement teams seek products that balance clinical effectiveness with predictable supply chains and service support. The confluence of evolving device architectures and procedural workflows has redefined expectations for catheter performance, particularly in complex peripheral vascular disease interventions where vessel tortuosity, thrombus burden, and access considerations vary widely.

Against this backdrop, stakeholders from clinicians to commercial leaders require an integrated perspective that synthesizes clinical innovation, regulatory precedence, and operational realities. New iterations of PMT catheters emphasize deliverability, control, and patient safety, and these attributes now play a dominant role in hospital and ambulatory center adoption decisions. As a result, competitive positioning is shaped by technical differentiation and post-market evidence-generation, while reimbursement and procurement cycles influence the pace at which novel devices transition from early adopters to broader clinical practice.

This introductory review provides a framework for understanding device intent, clinical utility, and market traction drivers, enabling readers to contextualize technical developments and strategic initiatives within a rapidly evolving clinical environment.

How converging forces in technology, care delivery models, regulatory expectations, and supply chain resilience are reshaping peripheral PMT catheter adoption pathways

The landscape for peripheral PMT catheters is being transformed by multiple, intersecting shifts that are reshaping clinical practice and commercial priorities. Technological evolution has accelerated with more sophisticated catheter designs that emphasize steerability and torque response to negotiate complex peripheral anatomies. These hardware improvements are reinforced by adjunctive imaging and device integration capabilities that improve lesion visualization and procedural precision, which in turn lower procedural times and reduce complication rates in experienced hands.

Simultaneously, care delivery models are migrating toward ambulatory and outpatient settings where cost pressures and throughput considerations demand devices that minimize procedural complexity and support rapid patient turnover. Hospitals are responding by prioritizing capital allocation toward devices that demonstrate operational efficiencies and predictable learning curves. At the same time, regulatory scrutiny and post-market surveillance mechanisms have intensified, prompting manufacturers to invest in robust clinical evidence and rigorous quality systems to support broader adoption and payer engagement.

In addition, supply chain resilience and localized manufacturing capabilities have gained prominence after recent global disruptions, motivating manufacturers and distributors to reassess distribution networks and inventory strategies. These cumulative shifts emphasize interoperability, clinical outcome validation, and the ability to deliver consistent performance across diverse care environments, all of which directly influence procurement decisions and long-term product viability.

Understanding how US tariff adjustments in 2025 are prompting supply chain reconfiguration, sourcing localization, and procurement strategies for peripheral PMT catheters

In 2025, tariff changes in the United States exert a tangible influence on procurement strategies and manufacturer distribution logic for peripheral PMT catheters. Increased import levies on medical devices and component parts prompt multinational manufacturers to reassess product flows, pricing structures, and localization plans to maintain market competitiveness. As organizations adapt, procurement leaders in hospitals and ambulatory centers respond by seeking alternative sourcing arrangements, longer-term contracts, and supplier partnerships that can mitigate short-term cost volatility while securing device availability.

The tariff environment also catalyzes discussions about local manufacturing and final assembly, encouraging some manufacturers to accelerate investments in regional production to reduce duty exposure and enhance supply chain control. Such moves carry capital and operational implications but can yield benefits in lead time reduction and regulatory alignment for devices intended for the U.S. clinical market. For smaller suppliers and distributors, tariff-driven cost pressures can compress margins and necessitate adjustments in sales strategies, including value-added services or differentiated warranty and training propositions to retain customers.

Clinicians and hospital administrators navigate these changes by emphasizing total cost of ownership and clinical value rather than unit price alone. Payors and purchasing groups increasingly expect transparent lifecycle cost data and may prefer suppliers that demonstrate both supply continuity and commitment to clinician education. The net effect of tariff shifts is a renewed focus on supply chain diversification, manufacturing footprint strategy, and contractual protections to safeguard clinical access and fiscal predictability.

A multidimensional segmentation framework revealing how application, end-user, product type, sales channels, and catheter size collectively shape clinical adoption and commercial strategy

Segmentation is central to interpreting demand dynamics, product development priorities, and go-to-market tactics for peripheral PMT catheters. When viewed through the lens of clinical application, devices are deployed across dialysis access management, embolization procedures, and peripheral vascular disease treatment; within the latter, operators select tools optimized for angioplasty adjuncts, atherectomy support, or targeted thrombectomy interventions depending on lesion characteristics and procedural intent. These clinical distinctions influence device features such as lumen size, aspiration capability, and compatibility with adjunctive devices.

From the perspective of end users, adoption pathways vary across ambulatory surgical centers, hospitals, and specialty clinics. Ambulatory centers often prioritize rapid turnover and user-friendly systems that lower staffing burden, hospitals require devices that integrate with complex imaging and support multidisciplinary teams, and specialty clinics emphasize targeted performance for high-volume disease types. These care setting differences shape training requirements, inventory policies, and purchasing cadences.

Product-type segmentation differentiates over-the-wire systems from rapid exchange platforms and specialty delivery systems; the latter category includes steerable designs and torque-control architectures that confer enhanced navigational precision in tortuous anatomy. Sales channel distinctions between direct sales and distributor sales influence commercial engagement models, with direct sales often enabling tailored corporate sales relationships and distributor networks providing breadth and logistical depth. Finally, catheter size is a practical differentiator, with large diameters greater than 3.5F, medium diameters ranging from 2.5 to 3.5F, and small diameters under 2.5F guiding clinician choice based on vessel access, thrombus burden, and procedural compatibility. Together, these segmentation axes provide a multidimensional framework that informs R&D priorities, clinical training investments, and market entry strategies.

How divergent regulatory frameworks, clinical practices, and procurement ecosystems across the Americas, Europe Middle East & Africa, and Asia-Pacific influence device strategy and market entry

Regional dynamics exert a material influence on regulatory pathways, clinical practice patterns, and commercial execution for peripheral PMT catheters. In the Americas, clinical adoption is driven by established interventional cardiology and radiology ecosystems, robust hospital procurement frameworks, and a rising emphasis on outpatient vascular care, all of which favor devices that demonstrate operational efficiency and clinician familiarity. The region's regulatory and reimbursement environments encourage evidence generation that links device performance to patient outcomes and cost containment.

Europe, Middle East & Africa present heterogeneous landscapes where regulatory frameworks vary significantly across jurisdictions and where healthcare delivery models range from centralized national health systems to private, fee-for-service clinics. Manufacturers operating in this combined region must navigate diverse approval processes and tailor clinical engagement strategies to local hospital procurement norms. Reimbursement models and varying resource availability influence device selection, making flexible pricing and training programs important to achieving broader penetration.

In Asia-Pacific, demand is shaped by rapid expansion of interventional facilities, increasing clinician specialization, and government-driven investments in healthcare infrastructure. Markets within the region differ in payer structure and regulatory maturity, prompting manufacturers to adapt clinical evidence packages and distribution approaches accordingly. Across these three regional clusters, success depends on aligning product portfolios with local procedural preferences, regulatory timelines, and supply chain realities to support sustainable adoption.

Competitive landscape dynamics where scale, focused innovation, and integrated service offerings determine differentiation and influence procurement decisions within the PMT catheter sector

Competitive dynamics in peripheral PMT catheters reflect the presence of established medical device manufacturers and emerging specialized firms that bring focused innovation in catheter design and procedural adjuncts. Incumbent device makers leverage broad clinical relationships, large-scale manufacturing, and integrated product portfolios to offer bundled solutions that encompass catheters, guidewires, and imaging accessories. Their scale enables investments in multicenter clinical studies, extensive training programs, and global distribution infrastructures that support hospital system adoption.

Smaller and specialized companies differentiate through rapid iteration, niche-focused design enhancements, and closer collaboration with key opinion leaders to refine device performance for specific clinical indications. These firms often compete on unique technical attributes such as enhanced steerability, improved aspiration mechanics, or proprietary clot fragmentation technologies. Partnerships and licensing arrangements between larger firms and innovators can accelerate commercialization while preserving the R&D agility of smaller players.

Distributors and regional partners play a pivotal role by extending reach into ambulatory centers and specialty clinics, offering logistical support and local training. The competitive battlefield increasingly includes services such as hands-on procedural training, digital education platforms, and data-driven post-market surveillance offerings. Ultimately, firms that combine compelling clinical evidence, responsive supply chains, and integrated service offerings are best positioned to influence purchasing committees and procedural leaders.

Actionable strategic initiatives for manufacturers and healthcare providers to align product development, evidence generation, and supply chain models with clinical and procurement priorities

Industry leaders can translate insights into competitive advantage through a set of targeted, actionable initiatives that align product design, commercial models, and evidence generation with evolving clinical and procurement expectations. First, prioritize modular product architectures that allow rapid customization of catheter attributes such as diameter and delivery configuration while limiting the complexity of inventory management. This approach reduces the logistical burden on high-volume centers and supports rapid clinician adoption across diverse case types.

Second, invest in robust clinical evidence programs that pair pragmatic outcomes data with health economics analyses; demonstrating procedural efficiency and patient recovery benefits will resonate with hospital purchasing committees and payers. Complementary to evidence generation, develop structured training and proctoring programs that shorten learning curves and reinforce consistent outcomes across user groups and care settings. These programs should be delivered through a combination of hands-on workshops, simulation, and digital learning platforms to scale effectively.

Third, reassess supply chain strategies by exploring regional manufacturing or final assembly options, strengthening distributor relationships, and negotiating flexible contract terms that address tariff-related risks. Fourth, refine commercial engagement by offering differentiated sales models that combine direct enterprise relationships for large systems with distributor-led coverage for ambulatory and specialty clinic segments. Finally, maintain a pipeline of iterative product improvements that respond to clinician feedback on navigation, aspiration efficacy, and compatibility with adjunctive devices, sustaining both clinical relevance and commercial momentum.

A transparent mixed-methods research approach combining clinician interviews, procurement insights, and technical literature synthesis to support reproducible strategic conclusions

The research underpinning this analysis integrates a cross-functional approach that synthesizes primary qualitative inputs with secondary technical and regulatory literature. Primary inputs include structured interviews with interventional physicians, procurement executives across hospitals and ambulatory centers, and commercial leaders responsible for distribution and sales strategy. These firsthand perspectives illuminate procedural preferences, purchasing rationales, and operational constraints that shape adoption patterns.

Secondary inputs incorporate device design specifications, regulatory filing summaries, peer-reviewed clinical literature on catheter-based thrombectomy techniques, and public information on commercial distribution models. Data interrogation emphasized device architecture features such as delivery mechanisms, size gradations, and integration with imaging modalities. Cross-validation between primary stakeholder insights and secondary documentation ensured that conclusions reflect both frontline clinical practice and broader industry trends.

Analytical methods included thematic synthesis of interview findings, comparative device feature mapping, and scenario-based assessment of supply chain and regulatory variables. The methodology prioritized transparency in assumptions and traceability of qualitative evidence to support reproducible interpretations and to aid readers in applying findings to their strategic contexts.

Concluding synthesis emphasizing the need to unite product innovation, clinical validation, and supply chain foresight to achieve durable adoption of peripheral PMT catheters

The peripheral PMT catheter environment is characterized by rapid technical refinement, shifting care delivery patterns, and heightened emphasis on supply chain resilience. Successful navigation of this environment requires alignment between clinical value propositions and pragmatic commercial execution. Clinicians seek devices that improve procedural precision and patient outcomes, while procurement teams demand predictable supply and demonstrable total cost benefits; manufacturers must bridge these priorities through evidence, training, and logistical reliability.

As the sector evolves, organizations that integrate iterative product innovation with robust clinical engagement and flexible supply strategies will be best positioned to influence adoption. Regional nuances in regulation and procurement necessitate tailored market approaches, and tariff-induced pressures accelerate considerations around localized manufacturing and contract design. Competitive advantage increasingly depends on the ability to deliver integrated solutions that combine technical differentiation with service-oriented commercial models that answer the needs of diverse care settings.

In sum, a holistic strategy that unites product engineering, clinical validation, and supply-chain foresight will enable stakeholders to translate technological progress into sustainable clinical and commercial outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripheral PMT Catheter Market, by Product Type

  • 8.1. Over The Wire
  • 8.2. Rapid Exchange
  • 8.3. Specialty Delivery Systems
    • 8.3.1. Steerable
    • 8.3.2. Torque Control

9. Peripheral PMT Catheter Market, by Catheter Size

  • 9.1. Large Diameter >3.5F
  • 9.2. Medium Diameter 2.5-3.5F
  • 9.3. Small Diameter <2.5F

10. Peripheral PMT Catheter Market, by Application

  • 10.1. Dialysis Access Management
  • 10.2. Embolization
  • 10.3. Peripheral Vascular Disease Treatment
    • 10.3.1. Angioplasty
    • 10.3.2. Atherectomy
    • 10.3.3. Thrombectomy

11. Peripheral PMT Catheter Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Peripheral PMT Catheter Market, by Sales Channel

  • 12.1. Direct Sales
  • 12.2. Distributor Sales

13. Peripheral PMT Catheter Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Peripheral PMT Catheter Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Peripheral PMT Catheter Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Peripheral PMT Catheter Market

17. China Peripheral PMT Catheter Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AngioDynamics, Inc.
  • 18.6. Argon Medical Devices, Inc.
  • 18.7. Becton, Dickinson and Company
  • 18.8. Boston Scientific Corporation
  • 18.9. Inari Medical, Inc.
  • 18.10. Koninklijke Philips N.V.
  • 18.11. Medtronic plc
  • 18.12. Merit Medical Systems, Inc.
  • 18.13. Penumbra, Inc.
  • 18.14. Teleflex Incorporated
  • 18.15. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERAL PMT CATHETER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERIPHERAL PMT CATHETER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PERIPHERAL PMT CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PERIPHERAL PMT CATHETER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY OVER THE WIRE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY OVER THE WIRE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY OVER THE WIRE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY RAPID EXCHANGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY RAPID EXCHANGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY RAPID EXCHANGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY STEERABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY STEERABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY STEERABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY TORQUE CONTROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY TORQUE CONTROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY TORQUE CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY LARGE DIAMETER >3.5F, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY LARGE DIAMETER >3.5F, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY LARGE DIAMETER >3.5F, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY MEDIUM DIAMETER 2.5-3.5F, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY MEDIUM DIAMETER 2.5-3.5F, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY MEDIUM DIAMETER 2.5-3.5F, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SMALL DIAMETER <2.5F, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SMALL DIAMETER <2.5F, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SMALL DIAMETER <2.5F, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY DIALYSIS ACCESS MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY DIALYSIS ACCESS MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY DIALYSIS ACCESS MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY EMBOLIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY EMBOLIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY EMBOLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY ANGIOPLASTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY ANGIOPLASTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY ANGIOPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY THROMBECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY THROMBECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY THROMBECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS PERIPHERAL PMT CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. GCC PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GCC PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. GCC PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 143. GCC PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 144. GCC PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. GCC PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 146. GCC PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. GCC PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. G7 PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. G7 PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. G7 PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 167. G7 PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. G7 PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. G7 PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 170. G7 PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. G7 PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. NATO PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. NATO PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NATO PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 175. NATO PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. NATO PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. NATO PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 178. NATO PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. NATO PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL PERIPHERAL PMT CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES PERIPHERAL PMT CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA PERIPHERAL PMT CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA PERIPHERAL PMT CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA PERIPHERAL PMT CATHETER MARKET SIZE, BY SPECIALTY DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA PERIPHERAL PMT CATHETER MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA PERIPHERAL PMT CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA PERIPHERAL PMT CATHETER MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA PERIPHERAL PMT CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA PERIPHERAL PMT CATHETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)